BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 3514234)

  • 1. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP; Griscelli C; Fischer A
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-nonself discrimination and repertoire selection of human T cells differentiated in an HLA-semiallogeneic environment following bone marrow transplantation for severe combined immunodeficiency.
    Knobloch C; Goldmann SF; Friedrich W
    Eur J Immunol; 1991 Oct; 21(10):2479-87. PubMed ID: 1833204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J
    Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE; Buckley RH
    J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary human keratinocytes as targets in predicting acute graft-versus-host disease following HLA-identical bone marrow transplantation.
    van Dijk AM; Kessler FL; Verdonck LF; Stadhouders-Keet SA; van Lier RA; de Gast GC; Otten HG
    Br J Haematol; 2000 Dec; 111(3):791-6. PubMed ID: 11122139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A SCID patient reconstituted with HLA-incompatible fetal stem cells as a model for studying transplantation tolerance.
    Roncarolo MG; Bacchetta R; Bigler M; Touraine JL; de Vries JE; Spits H
    Blood Cells; 1991; 17(2):391-402. PubMed ID: 1680508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patient.
    Tilkin AF; Bagot M; Kayibanda M; Vernant JP; Levy JP
    J Immunol; 1986 Dec; 137(12):3772-6. PubMed ID: 3537123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: autologous marrow recovery with specific immune sensitization to donor antigens.
    Sondel PM; Hank JA; Trigg ME; Kohler PC; Finlay JL; Blank J; Meisner L; Borcherding W; Hong R; Steeves R
    Exp Hematol; 1986 May; 14(4):278-86. PubMed ID: 3516715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.